Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 7/22/2025Simcere Zaiming Secures U.S. FDA Approval for IND of FGFR2b-Targeted A...
  • 7/22/2025AusperBio Cleared to Begin Phase III Trial of AHB-137 for Chronic HepB...
  • 7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...
  • 7/22/2025Innovent Secures IND for Oral GLP‑1 Agonist IBI3032 as Mazdutide Hits...
  • 7/18/2025SKBio Wins Chinese Clinical Trial Approval for GBP410
  • 7/18/2025Hengrui's SHR‑A1904 Emerges as Promising New Weapon Against Advanced ...
  • 7/18/2025China Approves First Homegrown Oral Anti‑Influenza Drug by Zenshine P...
  • 7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...
  • 7/18/2025China Approves Nation's First Recombinant Human Albumin Injection Deri...
  • 7/17/2025China Accepts Amgen and ONC Marketing Submission for Imdelltra in ES-S...
  • 7/16/2025AstraZeneca Secures First-Time Clinical Trial Approvals in China for F...
  • 7/16/2025Innovent Initiates Phase III Trial for IBI343 in Advanced Pancreatic C...
  • 7/15/2025China Clears IND for YolTech’s First-in-Class In Vivo Base Editing Th...
  • 7/15/2025Hengrui Prepares Chinese NDA for Kailera Drug After Phase 3 Obesity Wi...
  • 7/14/2025Shanghai Cell Therapy Unveils BZE2204: Rapid CAR‑T with Impressive Ef...
  • 7/14/2025Akeso Launches Phase II Study Combining BsAbs with Tinengotinib
  • 7/14/2025InnoCare Announces FDA Approval of Clinical Trial for BCL2 Inhibitor M...
  • 7/14/2025Ascentage's Lisaftoclax (APG‑2575) Gains NMPA Green Light for CLL/SLL
  • 7/11/2025Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches First Phase III T...
  • 7/11/2025Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...
  • 7/11/2025BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
  • 7/10/2025Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...
  • 7/9/2025Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...
  • 7/9/2025Hansoh Pharma Launches Phase 1 Trial of HS-20093 with Adebrelimab in F...
  • 7/8/2025ArkBio's ADHD Drug Azstarys Granted Priority Review in China
  • 7/8/2025DualityBio Launches Phase 3 Trial of HER2 ADC DB‑1303 in China for Re...
  • 7/8/2025Hansoh Launches Phase 1 Combo Trial of HS‑20093 ADC in ES‑SCLC
  • 7/8/2025SCG Cell's IND for SCG101V Cleared in China
  • 7/8/2025CStone Launches Global Phase I/II Trial for Trispecific Antibody CS200...
  • 7/4/2025Legend Initiates First-in-Human Trial for LUCAR-G19 in Autoimmune Dise...
  • Page:3/18 Total number of articles:534: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group